KRT18 and immune system disorder: We used transgenic mice expressing the human angiotensin I-converting enzyme 2 (ACE2) receptor driven by the cytokeratin-18 (K18) gene promoter (K18-hACE2), shown to be a model that mimics the clinical manifestations and immune disorders of severe COVID-19 infection in humans36,37.